Bringing precision oncology to cellular resolution with single-cell genomics.
1Department of Pediatrics, Division of Hematology/Oncology, Stanford University, Stanford, USA.
Clinical & Experimental Metastasis
|November 22, 2021
Summary
Single-cell sequencing reveals individual tumor cell characteristics, advancing cancer research. This technology offers a path toward personalized cancer treatments by identifying specific biomarkers and drug targets for clinical application.
Area of Science:
- Oncology
- Genomics
- Biotechnology
Background:
- Single-cell sequencing technologies have rapidly advanced in the last five years.
- These technologies fuel discoveries in cancer etiology, pathogenesis, and treatment responsiveness at the individual tumor cell level.
- Current advancements primarily focus on basic tumor biology.
Purpose of the Study:
- To provide an overview of single-cell cancer sequencing development.
- To outline a roadmap for translating these technologies from research to clinical diagnostics.
- To highlight opportunities for developing clone-specific combination treatment strategies.
Main Methods:
- Review of single-cell sequencing technology development in cancer research.
- Analysis of current applications and future potential in clinical oncology.
- Exploration of biomarker and drug target identification for subpopulations within tumors.
Main Results:
- Single-cell sequencing provides high-resolution details of tumor heterogeneity.
- Knowledge gained is beginning to identify clinically relevant biomarkers and drug targets.
- Opportunities exist for developing biologically-informed, clone-specific combination therapies.
Conclusions:
- Single-cell sequencing is transitioning from a basic research tool to a potential diagnostic instrument.
- These technologies can provide treatment-directing details for clinical oncologists.
- The field is paving the way for more personalized and effective cancer treatment strategies.
